Argent Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.8M Sell
73,979
-1,201
-2% -$280K 0.59% 41
2026
Q1
$18.4M Sell
75,180
-9,412
-11% -$2.19M 0.58% 46
2025
Q4
$17.5M Buy
84,592
+82,764
+4,528% +$16.4M 0.5% 43
2025
Q3
$339K Hold
1,828
0.01% 138
2025
Q2
$279K Hold
1,828
0.01% 143
2025
Q1
$303K Sell
1,828
-281
-13% -$44K 0.01% 143
2024
Q4
$305K Sell
2,109
-4,085
-66% -$633K 0.01% 146
2024
Q3
$1M Buy
6,194
+3
+0% +$478 0.03% 101
2024
Q2
$905K Hold
6,191
0.03% 95
2024
Q1
$979K Sell
6,191
-9
-0.1% -$1.43K 0.03% 93
2023
Q4
$972K Sell
6,200
-202
-3% -$31K 0.03% 98
2023
Q3
$997K Sell
6,402
-425
-6% -$70.1K 0.04% 97
2023
Q2
$1.13M Buy
6,827
+201
+3% +$32.4K 0.04% 98
2023
Q1
$1.03M Buy
6,626
+20
+0.3% +$3.23K 0.04% 102
2022
Q4
$1.17M Buy
6,606
+232
+4% +$40.1K 0.04% 100
2022
Q3
$1.04M Sell
6,374
-59
-0.9% -$9.98K 0.04% 103
2022
Q2
$1.14M Sell
6,433
-144
-2% -$25.7K 0.04% 102
2022
Q1
$1.17M Sell
6,577
-257
-4% -$43.7K 0.04% 105
2021
Q4
$1.17M Hold
6,834
0.03% 111
2021
Q3
$1.1M Sell
6,834
-75
-1% -$12.8K 0.03% 110
2021
Q2
$1.14M Buy
6,909
+2
+0% +$331 0.04% 111
2021
Q1
$1.14M Sell
6,907
-26
-0.4% -$4.21K 0.04% 107
2020
Q4
$1.09M Sell
6,933
-74
-1% -$10.9K 0.04% 110
2020
Q3
$1.04M Buy
7,007
+2
+0% +$296 0.04% 139
2020
Q2
$985K Sell
7,005
-38
-0.5% -$5.54K 0.04% 137
2020
Q1
$924K Sell
7,043
-33
-0.5% -$4.68K 0.04% 132
2019
Q4
$1.03M Sell
7,076
-1,601
-18% -$217K 0.04% 153
2019
Q3
$1.12M Sell
8,677
-90
-1% -$11.9K 0.04% 142
2019
Q2
$1.22M Sell
8,767
-7,961
-48% -$1.1M 0.05% 131
2019
Q1
$2.34M Sell
16,728
-274
-2% -$36.7K 0.09% 98
2018
Q4
$2.19M Buy
17,002
+111
+0.7% +$15.5K 0.11% 93
2018
Q3
$2.33M Buy
16,891
+2,800
+20% +$372K 0.08% 111
2018
Q2
$1.71M Sell
14,091
-159,668
-92% -$19.9M 0.06% 118
2018
Q1
$22.3M Sell
173,759
-5,290
-3% -$715K 0.81% 37
2017
Q4
$24.7M Sell
179,049
-18
-0% -$2.51K 0.85% 34
2017
Q3
$23.3M Buy
179,067
+22,802
+15% +$3.02M 0.9% 33
2017
Q2
$20.7M Sell
156,265
-31,744
-17% -$4.05M 0.83% 35
2017
Q1
$23.4M Sell
188,009
-310
-0.2% -$37K 0.89% 35
2016
Q4
$21.7M Buy
188,319
+3,599
+2% +$416K 0.88% 38
2016
Q3
$21.8M Sell
184,720
-99
-0.1% -$12K 0.94% 35
2016
Q2
$22.4M Buy
184,819
+666
+0.4% +$75.7K 1% 35
2016
Q1
$19.9M Buy
184,153
+2,536
+1% +$263K 0.91% 36
2015
Q4
$18.7M Buy
181,617
+55,153
+44% +$5.55M 0.87% 37
2015
Q3
$11.8M Buy
126,464
+1,186
+0.9% +$115K 0.59% 47
2015
Q2
$12.2M Sell
125,278
-243
-0.2% -$24.3K 0.56% 48
2015
Q1
$12.6M Buy
125,521
+1,685
+1% +$171K 0.57% 48
2014
Q4
$12.9M Buy
123,836
+18,870
+18% +$1.99M 0.62% 47
2014
Q3
$11.2M Sell
104,966
-2,974
-3% -$308K 0.61% 47
2014
Q2
$11.3M Sell
107,940
-305
-0.3% -$30.8K 0.6% 47
2014
Q1
$10.6M Buy
108,245
+3,750
+4% +$348K 0.58% 48
2013
Q4
$9.57M Buy
104,495
+470
+0.5% +$43.3K 0.54% 46
2013
Q3
$9.02M Sell
104,025
-15
-0% -$1.35K 0.55% 46
2013
Q2
$8.93M Buy
+104,040
New +$8.83M 0.57% 44

Other funds holding JNJ

Argent Capital Management's JNJ Position: Q2 2026 in Review

Argent Capital Management reduced its Johnson & Johnson (JNJ) stake by 1.6% in Q2 2026, selling an estimated $280K and leaving 73,979 shares worth $18.8M. The position accounts for 0.59% of the portfolio, ranked #41.

Argent Capital Management first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $24.7M in Q4 2017. 823 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Argent Capital Management held 73,979 shares of Johnson & Johnson worth $18.8M as of Q2 2026.
  • Argent Capital Management sold 1,201 Johnson & Johnson shares in Q2 2026, an estimated $280K.
  • Johnson & Johnson made up 0.59% of Argent Capital Management's portfolio in Q2 2026, its #41 holding.
  • Argent Capital Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Argent Capital Management's Johnson & Johnson position peaked at $24.7M in Q4 2017.
  • 823 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Argent Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.